The use of artificial intelligence across biopharma and life science tools and services is developing quickly. Will A.I. become a major disruptive technology in healthcare with the potential to significantly enhance productivity, reduce time spent in drug discovery, and optimize manufacturing processes? Sel Hardy says that the implementation could positively impact revenue growth and margin expansion in the long run.